Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us


Growing Prevalence of Chronic Diseases among Elderly Population to Drive Demand for Hemostasis Products

Blog Description

There has been a substantial growth of the hemostasis products market in the last few years due to various research and development activities undertaken by key players in this field, enabling the development of newer and innovative products. In addition to this, R&D activities have also led to the introduction of reliable hemostasis products, which are highly useful for emergency situations. Moreover, these new products are being positively received by the approval agencies at the national and international level. Thus, tremendous growth of the market can be expected in the coming years. 

Browse the full Global Hemostasis Products Market Report:

Growing Incidences of Trauma and Accidents to Drive Demand for Hemostasis Products

One of the key reasons behind the increased demand for hemostasis products is the rising number of accidents and thus, the need to carry out complicated surgeries. As per the World Health Organization (WHO), every year, 1.25 mn people are killed in road accidents across the globe. Increasing incidences of trauma, excessive bleeding, and hemorrhage are driving the demand for hemostasis products across the globe. Another factor, aiding the growth of the market is the growing geriatric population. The number of people aged above 65 who are vulnerable to several chronic diseases has created the need for complex surgeries and this is boosting the demand for hemostasis products worldwide.

Patent Expiries of Key Hemostasis Products to Impact Market

The global hemostasis products market is expected to face challenge in the form of patent expiries of some of the key hemostasis products. Patent expiries are significantly reducing the overall profitability. Patient expiries are encouraging the adoption of cheap biosimilars, thus impacting the global hemostasis products market negatively. In addition to this, strict approval policies by approval agencies have intensified the competition among manufacturers. Diverse dissimilarities among regulatory policies across regions and countries are deterring manufacturers from developing and introducing newer hemostasis products. This will hamper the growth of the market in the coming years.

Developing Nations to Offer Growth Opportunities in Future

The demand for hemostasis products is expected to increase from developing nations of Asia Pacific and Latin America. There exists a rising demand for advanced and efficient healthcare facilities from the emerging middle class population in these countries. Moreover, the growing geriatric population in these developing nations will also create a heightened demand for hemostasis products in the coming years. In addition to this, rising disposable income of people in emerging nations of Asia Pacific and Latin America will also aid the growth of the market.

Browse the full Press Release of Global Hemostasis Products Market at :

Key Players to Focus on Expanding Businesses in Untapped Markets

The global hemostasis products market is fairly consolidated with players such as Pfizer Inc., CR Bard, Inc., Ethicon, and Baxter International, Inc. holding significant shares of the market. Regional players are also contributing to the market. These key players are extensively focusing on product innovation to gain a competitive edge. Players are also investing heavily on research and development to ensure innovative product development. Moreover, key players are focusing on the untapped markets in emerging nations of Asia Pacific and Latin America as part of their growth strategy.